AlphaYouSH
Insider selling
Stephen Hoge sold $2.7M of Moderna, Inc. (MRNA) stock
Stephen Hoge, President of Moderna, Inc. (MRNA), sold 53,336 shares of MRNA stock worth $2.7M, per an SEC Form 4 filed Jun 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 15, 2026, 2 days before it was made public.
MRNA has moved +250.2% since the trade date, from $52.13 to $182.56 (Sep 22, 2026 close).
- Traded
- Jun 15, 2026
- Disclosed
- Jun 17, 2026
- Filing delay
- 2 days
- Price since
- +250.2%
- Role
- President
- Source
- SEC Form 4
More MRNA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.